Susquehanna International Group, LLP Gilead Sciences, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $75.7 Million - $95.5 Million	-1,136,700 Reduced 29.86%	2,670,500 $224 Million
Q2 2024 Aug 15, 2024	BUY	$63.15 - $72.88 $111 Million - $128 Million	1,758,600 Added 85.84%	3,807,200 $261 Million
Q1 2024 May 07, 2024	SELL	$71.58 - $87.29 $18.1 Million - $22.1 Million	-252,900 Reduced 10.99%	2,048,600 $150 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $271,099 - $307,433	3,700 Added 0.16%	2,301,500 $186 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $22 Million - $24 Million	297,100 Added 14.85%	2,297,800 $172 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $15.4 Million - $17.6 Million	-202,700 Reduced 9.2%	2,000,700 $154 Million
Q1 2023 May 16, 2023	SELL	$77.31 - $88.08 $74.3 Million - $84.6 Million	-961,000 Reduced 30.37%	2,203,400 $183 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $75.5 Million - $108 Million	1,211,600 Added 62.04%	3,164,400 $272 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $33.2 Million - $37.9 Million	-558,000 Reduced 22.22%	1,952,800 $120 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $60.3 Million - $67.9 Million	-1,044,400 Reduced 29.38%	2,510,800 $155 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $118 Million - $148 Million	-2,037,600 Reduced 36.43%	3,555,200 $211 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $65.7 Million - $74.5 Million	1,012,000 Added 22.09%	5,592,800 $406 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $130 Million - $140 Million	-1,914,900 Reduced 29.48%	4,580,800 $320 Million
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $133 Million - $146 Million	-2,103,100 Reduced 24.46%	6,495,700 $447 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $259 Million - $295 Million	4,310,700 Added 100.53%	8,598,800 $556 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $65.1 Million - $74.2 Million	-1,149,100 Reduced 21.13%	4,288,100 $250 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $15.6 Million - $19.6 Million	-250,800 Reduced 4.41%	5,437,200 $344 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $268 Million - $311 Million	-3,705,400 Reduced 39.45%	5,688,000 $438 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $317 Million - $406 Million	5,058,000 Added 116.67%	9,393,400 $702 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $54 Million - $59.4 Million	876,600 Added 25.34%	4,335,400 $282 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $43.8 Million - $48.3 Million	700,300 Added 25.39%	3,458,800 $219 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $26.6 Million - $29.8 Million	-430,200 Reduced 13.49%	2,758,500 $186 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $33.9 Million - $38 Million	-542,300 Reduced 14.53%	3,188,700 $207 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $2.16 Million - $2.81 Million	-35,600 Reduced 0.95%	3,731,000 $233 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $29.6 Million - $32.8 Million	415,000 Added 12.38%	3,766,600 $291 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $61 Million - $71.1 Million	-940,000 Reduced 21.9%	3,351,600 $237 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $106 Million - $129 Million	-1,448,500 Reduced 25.23%	4,291,600 $324 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $15.1 Million - $17.7 Million	-211,800 Reduced 3.56%	5,740,100 $411 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $429 Million - $509 Million	5,951,900	5,951,900 $482 Million

Others Institutions Holding GILD

# of Institutions

1,942

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.12 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.75 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.6 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account